key: cord-0882682-hrhmtyfl authors: Jokela, P.; Jääskeläinen, A. E.; Jarva, H.; Holma, T.; Ahava, M.; Mannonen, L.; Lappalainen, M.; Kurkela, S.; Loginov, R. title: SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility date: 2020-07-08 journal: nan DOI: 10.1101/2020.07.03.20145383 sha: f6472f258cade167da460e574b617b20165c47bf doc_id: 882682 cord_uid: hrhmtyfl Rapid sample-to-answer tests for detection of SARS-CoV-2 are emerging and data on their relative performance is urgently needed. We evaluated the analytical performance of two rapid nucleic acid tests, Cepheid Xpert(R) Xpress SARS-CoV-2 and Mobidiag Novodiag(R) Covid-19, in comparison to a combination reference of three large-scale PCR tests. Moreover, utility of the Novodiag(R) test in tertiary care emergency departments was assessed. In the preliminary evaluation, analysis of 90 respiratory samples resulted in 100% specificity and sensitivity for Xpert(R), whereas analysis of 107 samples resulted in 93.4% sensitivity and 100% specificity for Novodiag(R). Rapid SARS-CoV-2 testing with Novodiag(R) was made available for four tertiary care emergency departments in Helsinki, Finland between 18 and 31 May, coinciding with a rapidly declining epidemic phase. Altogether 361 respiratory specimens, together with relevant clinical data, were analyzed with Novodiag(R) and reference tests: 355/361 of the specimens were negative with both methods, and 1/361 was positive in Novodiag(R) and negative by the reference method. Of the 5 remaining specimens, two were negative with Novodiag(R), but positive with the reference method with late Ct values. On average, a test result using Novodiag(R) was available nearly 8 hours earlier than that obtained with the large-scale PCR tests. While the performance of novel sample-to-answer PCR tests need to be carefully evaluated, they may provide timely and reliable results in detection of SARS-CoV-2 and thus facilitate patient management including effective cohorting. of COVID-19 in Finland. Three of these emergency departments are located within 1 km 111 from our laboratory, where the testing was performed, and one is located at a distance of 13 112 km. It was agreed that rapid testing would be primarily targeted for those patients who were 113 likely to be hospitalized, and tests would be requested according to clinical assessment. The 114 specimens first underwent rapid PCR testing with Novodiag ® , and the result was immediately 115 reported. Directly after pipetting the Novodiag ® cassette, the specimen was subjected to one 116 of the three reference tests for confirmation and for the purposes of clinical evaluation. Statistical analysis 119 Concordance of the results obtained by the Novodiag ® and Xpert ® assays in comparison to a 120 combination reference of the three large-scale PCR tests was examined in McNemar's test. 121 Statistical significance was set at P < 0.05. To assess the agreement between the methods by 122 chance, Cohen's kappa coefficient () was computed. Mann-Whitney U test was used to 123 compare the Ct value medians, and the turnaround times of Novodiag ® and the three large- CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 8, 2020 . . https://doi.org/10.1101 /2020 Analytical evaluation 130 The results of the analytical evaluation are summarized in Table 2 Table 3 . In analysis of the proficiency samples, Novodiag ® failed to detect two 144 SARS-CoV2 containing samples with 3.3 log10 and 2.3 log10 copies/ml, the lowest 145 concentrations in the panel. Other respiratory viruses, including seasonal coronaviruses OC43 and 229E, did not cause 147 any false positive test results in this material including patient and proficiency samples. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 8, 2020. . https://doi.org/10. 1101 /2020 The clinical evaluation included 362 samples analyzed by Novodiag ® and reference PCR test 153 from 356 patients attending tertiary care emergency departments. One specimen was 154 excluded from further analyses due to invalid sampling control detected by Novodiag ® . The 155 remaining 361 samples were collected from 356 patients with a median age of 72 years. The 156 patients consisted of 34 children (median age of 5 years) and 322 adults (median age of 74 hypertension, psoriasis) and he succumbed to the infection after 2 days in the hospital. Intensive care was not considered useful. 178 5) 16-year-old male, whose medical data is not available. The one patient who was positive for SARS-CoV-2 according to Novodiag ® but negative in a 180 reference test, was a 53-year-old man with acute myocardial infarction, no fever or other 181 symptoms suggesting COVID-19. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 8, 2020. In the analytical performance assessment of this study, Xpert ® showed complete concordance 203 of results with the reference and the kappa value of 1.00 implied an almost perfect agreement. The high sensitivity and specificity of 100% observed for Xpert ® in this study has also been 205 shown in previous reports (7-9). CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 8, 2020. . https://doi.org/10.1101/2020.07.03.20145383 doi: medRxiv preprint need for placing the Novodiag ® instrument inside a biosafety cabinet. This, together with Indeed, implementation of the Novodiag ® provided results nearly 8 hours faster as compared 241 to the large-scale PCR tests. A limitation of the present study is the use of three different large-scale PCR tests for 243 reference, as analysis of all samples on one platform was not possible due to the global 244 shortage in testing supplies at the time of the study and a heavy load of samples to be tested. As a limitation, it should also be noted that age distribution and clinical information was 246 available only for the samples of the clinical evaluation. In conclusion, the Xpert ® Xpress SARS-CoV-2 showed high sensitivity and specificity, and a 248 reasonable sensitivity and high specificity was achieved for the Novodiag ® Covid-19 assay. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 8, 2020. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 8, 2020. . https://doi.org/10.1101/2020.07.03.20145383 doi: medRxiv preprint asymptomatic SARS-CoV-2 infection. Clinical Infectious Diseases 4:ciaa711. DOI: 339 101093/cid/ciaa711. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 8, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 8, 2020. . https://doi.org/10.1101/2020.07.03.20145383 doi: medRxiv preprint Table 5 . Performance of the Novodiag® Covid-19 assay and the Xpress® SARS-CoV-2 assay in the preliminary evaluation. Agreement compared to combination reference Laboratory diagnosis of emerging human 268 coronavirus infections -the state of the art Reference Novodiag® Covid-19 Reference Novodiag® Covid-19, n=106 No/reference Agreement % (95% CI) No/reference Agreement % (95% CI) 257 We would like to thank the nursing staff at our laboratory, especially Jonna Keijama, for the 258 valuable technical assistance.